UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001957
Receipt number R000002383
Scientific Title A prospective randomized trial of Billroth-I versus Billroth-II reconstruction after pancreaticoduodenectomy with pancreaticogastrostomy reconstruction
Date of disclosure of the study information 2009/05/11
Last modified on 2015/05/13 20:55:58

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A prospective randomized trial of Billroth-I versus Billroth-II reconstruction after pancreaticoduodenectomy with pancreaticogastrostomy reconstruction

Acronym

A prospective randomized trial of Billroth-I versus Billroth-II reconstruction after pancreaticoduodenectomy

Scientific Title

A prospective randomized trial of Billroth-I versus Billroth-II reconstruction after pancreaticoduodenectomy with pancreaticogastrostomy reconstruction

Scientific Title:Acronym

A prospective randomized trial of Billroth-I versus Billroth-II reconstruction after pancreaticoduodenectomy

Region

Japan


Condition

Condition

pancreatic tumor, bile duct tumor, ampullary tumor, duodenal tumor

Classification by specialty

Surgery in general Gastrointestinal surgery Hepato-biliary-pancreatic surgery
Operative medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Prospective randomized study for Billroth I versus Billroth II about postoperative complication and digestive ability after pancreaticoduodenectomy with pancreaticogastrostomy reconstruction

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase III


Assessment

Primary outcomes

Incidence of DGE and postoperative hospital stay in the postoeprative early period.

Key secondary outcomes

Evaluation of nutriture, digestive ability, and pancreatic endocrine/exocrine secretory function in the postoperative late period.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

Active

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Perform Billroth I reconstruction after pancreaticoduodenectomy.

Interventions/Control_2

Perform Billroth II reconstruction after pancreaticoduodenectomy.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

Cases with pancreatic tumor, bile duct tumor, ampullary tumor, or duodenal tumor who received macroscopic curative resection by pancreticoduodenectomy.
Performance status 0 or 1.

Key exclusion criteria

Case who did not received curative resection for cancer.
Performance status 2 or 3.

Target sample size

90


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroshi Kurahara

Organization

Kagoshima University

Division name

Surgical Oncology and Digestive Surgery

Zip code


Address

8-35-1, Sakuragaoka, Kagoshima

TEL

099-275-5361

Email

h-krhr@m3.kufm.kagoshima-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hiroshi Kurahara

Organization

Kagoshima University

Division name

Surgical Oncology and Digestive Surgery

Zip code


Address

8-35-1, Sakuragaoka, Kagoshima

TEL

099-275-5361

Homepage URL


Email

h-krhr@m3.kufm.kagoshima-u.ac.jp


Sponsor or person

Institute

Graduate School of Medical Sciences Kagosima University

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

YES

Study ID_1

20-46

Org. issuing International ID_1

Kagoshima University

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

鹿児島大学病院


Other administrative information

Date of disclosure of the study information

2009 Year 05 Month 11 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2008 Year 08 Month 29 Day

Date of IRB


Anticipated trial start date

2008 Year 09 Month 01 Day

Last follow-up date

2011 Year 08 Month 01 Day

Date of closure to data entry

2012 Year 04 Month 01 Day

Date trial data considered complete

2012 Year 04 Month 01 Day

Date analysis concluded

2012 Year 04 Month 01 Day


Other

Other related information



Management information

Registered date

2009 Year 05 Month 11 Day

Last modified on

2015 Year 05 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002383


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name